A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Cholinesterase, Plasma (CA Clients)
Test Code90368
CPT Codes
82480
Preferred Specimen
1 mL plasma collected in a EDTA (lavender-top) tube
Minimum Volume
0.5 mL
Other Acceptable Specimens
Plasma collected in: PPT potassium EDTA (white-top) tube
Instructions
Draw an EDTA (lavender-top) tube of whole blood. Spin tube to separate plasma. Pour plasma into plastic aliquot tube and refrigerate until shipping. Do not send packed cells. Do not send one tube of whole blood.
Plasma cholinesterase results are not accurate if plasma sample is not separated from RBCs in a timely manner (within 1 hr). Hemolysis can lead to apparent increases in plasma cholinesterase activity, and could mask an enzyme deficiency.
Note: PPT potassium EDTA (white-top) tubes should be centrifuged within 24 hours.
Plasma cholinesterase results are not accurate if plasma sample is not separated from RBCs in a timely manner (within 1 hr). Hemolysis can lead to apparent increases in plasma cholinesterase activity, and could mask an enzyme deficiency.
Note: PPT potassium EDTA (white-top) tubes should be centrifuged within 24 hours.
Transport Container
Transport tube
Transport Temperature
Refrigerated (cold packs)
Specimen Stability
Room temperature: 21 days
Refrigerated: 21 days
Frozen: 30 days
Refrigerated: 21 days
Frozen: 30 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Hemolysis
Methodology
Kinetic Spectrophotometric (KS)
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
This test code is for California patient testing. For non-California testing, use test code 335.
Setup Schedule
Tues-sat
Report Available
2-5 days
Limitations
Results may be depressed in patients who consume oral contraceptives. Hepatic disease may cause up to a 70% decrease in enzyme levels. Cholinesterase may be slightly elevated in patients with obesity or diabetes.
Reference Range
Male | 3334-7031 IU/L |
Female | 2504-6297 IU/L |
Clinical Significance
Approximately 1 in every 2500 individuals has inherited a defective enzyme or a deficiency of the enzyme (Pseudocholinesterase) that metabolizes succinylcholine (an anesthetic agent). With a "normal" dosage, these individuals have prolonged apnea. Such individuals are responsive at much smaller concentrations of this anesthetic agent than the general population. Low concentrations of Pseudocholinesterase are observed in individuals exposed to organophosphorous insecticides and in patients with hepatic dysfunction.
Performing Laboratory
Quest Diagnostics Nichols Institute-San Juan Capistrano, CA |
33608 Ortega Highway |
San Juan Capistrano, CA 92675-2042 |
Last Updated: November 6, 2024